Inferential statistics of treatment outcome measures for complete cases: means, SD and N
| Baseline | Post-treatment | 3-month follow-up | ||||
| Intervention | Control | Intervention | Control | Intervention | Control | |
| N | 331 | 349 | 96 | 141 | 81 | 113 |
| Primary | ||||||
| PHQ-9 | 16.47 (4.12) | 16.29 (4.10) | 9.34 (6.10) | 13.57 (5.51) | 9.11 (5.57) | 12.09 (5.83) |
| WHODAS | 31.92 (8.44) | 31.73 (8.06) | 24.40 (8.57) | 28.02 (9.07) | 25.20 (9.30) | 26.64 (9.28) |
| Secondary | ||||||
| WHO-5 | 6.49 (3.99) | 7.02 (4.33) | 10.42 (5.73) | 8.50 (5.47) | 11.31 (5.48) | 8.82 (5.23) |
| GAD-7 | 15.92 (4.71) | 15.92 (4.64) | 10.08 (5.62) | 14.30 (5.64) | 9.99 (5.35) | 12.89 (5.94) |
| PCL-5 | 19.88 (6.19) | 20.18 (6.27) | 13.88 (7.34) | 17.81 (6.92) | 13.05 (7.91) | 16.41 (8.33) |
| PSYCHLOPS | 16.69 (3.54) | 16.74 (3.39) | 10.08 (4.84) | 13.75 (4.64) | 9.21 (5.06) | 11.96 (5.63) |
GAD-7, Generalised Anxiety Disorder 7; PCL-5, Post-Traumatic Stress Disorder Checklist 5; PHQ-9, Patient Health Questionnaire 9; PSYCHLOPS, Psychological Outcomes Profile; WHODAS, WHO Disability Assessment Schedule-12.